[1] Liberal R,Grant CR,Mieli-Vergani G,et al. Autoimmune hepatitis:a comprehensive review. J Autoimmun,2013,41:126-139.
[2] Czaja AJ,Carpenter HA. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology,2006,43:532-538.
[3] Czaja AJ,Donaldson PT. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am J Gastroenterol,2002,97:2051-2057.
[4] Murasko DM,Goonewardene IM. T-cell function in aging:mechanisms of decline. Annu Rev Gerontol Geriatr,1990,10:71-96.
[5] Schramm C,Kanzler S,Zum Buschenfelde KH,et al. Autoimmune hepatitis in the elderly. Am J Gastroenterol,2001,96:1587-1591.
[6] Czaja AJ. Clinical features,differential diagnosis and treatment of autoimmune hepatitis in the elderly. Drugs Aging,2008,25:219-239.
[7] Czaja AJ.Autoimmune liver disease and rheumatic manifestations. Curr Opin Rheumatol,2007,19（1）:74-80.
[8] Al-Chalabi T,Boccato S,Portmann BC,et al. Autoimmune hepatitis （AIH） in the elderly:a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol,2006,45:575-583.
[9] Hennes EM,Zeniya M,Czaja AJ,et al. Simplified criteria for the diagnosisof autoimmune hepatitis.Hepatology,2008,48:169-176.
[10] Verslype C,George C,Buchel E,et al. Diagnosis and treatment of autoimmune hepatitisat age 65 and older. Aliment Pharmacol Ther,2005,21:695-699.
[11] Czaja AJ. Rapidity of treatment response and outcome in type 1 autoimmune hepatitis. J Hepatol,2009,51:161-167.
[12] Cross TJ,Antoniades CG,Muiesan P,et al. Liver transplantation in patients over 60and 65 years:an evaluation of long-term outcomes and survival. Liver Transpl,2007,13:1382-1388.
[13] Manns MP,Woynarowski M,KreiselW,et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis.Gastroenterology,2010,139:1198-1206.
[14] Montano-Loza AJ,Carpenter HA,Czaja AJ. Features associated with treatment failure in type 1 autoimmunehepatitis and predictive value of the model of end-stage liverdisease. Hepatology,2007,46（4）：1138-1145.
[15] Cross TJS,Antoniades CG,Muiesan P,et al. Liver transplantation in patients over 60 and 65 years：an evaluation of long-term outcomes and survival. LiverTranspl,2007,13（10）：1382-1388.
[16] Manns MP,Czaja AJ,Gorham JD,et al. Practice Guidelines of the American Association for the Study of Liver Diseases.Diagnosis and management of autoimmune hepatitis.Hepatology,2010,51：2193-2213. |
